Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Sees Large Growth in Short Interest

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) was the target of a significant increase in short interest in October. As of October 30th, there was short interest totaling 2,838 shares, an increase of 1,319.0% from the October 15th total of 200 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 2,344 shares, the days-to-cover ratio is presently 1.2 days.

Santen Pharmaceutical Stock Performance

Santen Pharmaceutical stock traded up $0.06 on Tuesday, hitting $12.73. 1,894 shares of the stock traded hands, compared to its average volume of 2,256. The business’s fifty day simple moving average is $11.16 and its 200 day simple moving average is $11.53. Santen Pharmaceutical has a 1 year low of $9.50 and a 1 year high of $13.93.

Santen Pharmaceutical Company Profile

Santen Pharmaceutical is a Japan-based pharmaceutical company focused on eye care. Founded in 1890, it researches, develops, manufactures and markets treatments for ophthalmic conditions. Its products include prescription medicines for conditions such as glaucoma, dry eye and retinal diseases, as well as over-the-counter eye drops and other eye-care products. The company also offers products for eye surgery and related medical needs. Headquartered in Osaka, Santen serves patients and healthcare professionals in Japan and international markets, including other parts of Asia, Europe and the Middle East and Africa.